1. Home
  2. AAME vs RVPH Comparison

AAME vs RVPH Comparison

Compare AAME & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAME
  • RVPH
  • Stock Information
  • Founded
  • AAME 1968
  • RVPH 2006
  • Country
  • AAME United States
  • RVPH United States
  • Employees
  • AAME N/A
  • RVPH N/A
  • Industry
  • AAME Life Insurance
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • AAME Finance
  • RVPH Health Care
  • Exchange
  • AAME Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • AAME 35.9M
  • RVPH 32.8M
  • IPO Year
  • AAME N/A
  • RVPH N/A
  • Fundamental
  • Price
  • AAME $2.08
  • RVPH $0.34
  • Analyst Decision
  • AAME
  • RVPH Strong Buy
  • Analyst Count
  • AAME 0
  • RVPH 5
  • Target Price
  • AAME N/A
  • RVPH $9.00
  • AVG Volume (30 Days)
  • AAME 7.9K
  • RVPH 2.4M
  • Earning Date
  • AAME 08-13-2025
  • RVPH 08-13-2025
  • Dividend Yield
  • AAME 0.98%
  • RVPH N/A
  • EPS Growth
  • AAME N/A
  • RVPH N/A
  • EPS
  • AAME N/A
  • RVPH N/A
  • Revenue
  • AAME $191,355,000.00
  • RVPH N/A
  • Revenue This Year
  • AAME N/A
  • RVPH N/A
  • Revenue Next Year
  • AAME N/A
  • RVPH N/A
  • P/E Ratio
  • AAME N/A
  • RVPH N/A
  • Revenue Growth
  • AAME 2.04
  • RVPH N/A
  • 52 Week Low
  • AAME $1.25
  • RVPH $0.30
  • 52 Week High
  • AAME $2.22
  • RVPH $4.28
  • Technical
  • Relative Strength Index (RSI)
  • AAME 68.83
  • RVPH 27.45
  • Support Level
  • AAME $1.73
  • RVPH $0.72
  • Resistance Level
  • AAME $2.22
  • RVPH $0.83
  • Average True Range (ATR)
  • AAME 0.13
  • RVPH 0.07
  • MACD
  • AAME 0.02
  • RVPH -0.03
  • Stochastic Oscillator
  • AAME 65.45
  • RVPH 9.67

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: